The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Effects of the Serotonin Transporter Gene Promoter Polymorphism onMirtazapine and Paroxetine Efficacy and Adverse Events in Geriatric MajorDepression
Abstract
BACKGROUND: The "long/short"polymorphism (5HTTLPR) in the promoter of the serotonin transporter gene (SLC6A4) has been proposed as a pharmacogenetic marker for antidepressant efficacy. Some but not all studies have found that the short form of 5HTTLPR (S allele) results in decreased efficacy of selective serotonin reuptake inhibitors. OBJECTIVE: To determine if the 5HTTLPR polymorphism influences the efficacy and tolerability of mirtazapine and paroxetine hydrochloride, 2 frequently prescribed antidepressants with differing pharmacologic profiles, in geriatric depression. DESIGN: Double-blind, randomized 8-week study. SETTING: Eighteen academic and private outpatient clinics. PATIENTS: We evaluated 246 cognitively intact patients 65 years or older with major depression. INTERVENTIONS: Antidepressant therapy with 15 to 45 mg/d of mirtazapine (n = 124) or 20 to 40 mg/d of paroxetine (n = 122). MAIN OUTCOME MEASURES: The Hamilton Depression Rating Scale-17 and Geriatric Depression Scale, severity of adverse events and dosing compliance indexes, and discontinuations due to adverse events. Outcome measures were stratified according to 5HTTLPR genotypes. RESULTS: Geriatric Depression Scale scores indicated that S allele carriers treated with paroxetine showed a small impairment in antidepressant response. Among mirtazapine-treated patients, there was little indication that the 5HTTLPR genotype affected antidepressant efficacy. However, the 5HTTLPR polymorphism had a dramatic effect on adverse events. Among paroxetine-treated subjects, S allele carriers experienced more severe adverse events during the course of the study, achieved significantly lower final daily doses, and had more discontinuations at days 14, 21, 28, 42, and 49. Surprisingly, among mirtazapine-treated subjects, S allele carriers had fewer discontinuations due to adverse events, experienced less severe adverse events, and achieved higher final daily doses. CONCLUSIONS: These results support the hypothesis that the S allele of 5HTTLPR at the SLC6A4 locus is associated with a poor outcome after treatment with selective serotonin reuptake inhibitors. However, the major effect was on the tolerability of these drugs rather than efficacy. Results from mirtazapine-treated patients indicate that the effect of this polymorphism on outcome may depend on the mechanism of antidepressant action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Smeraldi, E., Zanardi, R., Benedetti, F., Bella, D. D., Perez, J., & Catalano, M. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000425 · Cited by 614
Greenberg, B. D., Tolliver, T. J., Huang, S.-J., Li, Q., Bengel, D., & Murphy, D. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990205)88:1<83::aid-ajmg15>3.0.co;2-0 · Cited by 533
Heinz, A., Jones, D. W., Mazzanti, C., Goldman, D., Ragan, P., Hommer, D., Linnoila, M., & Weinberger, D. R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00171-7 · Cited by 466
Pollock, B. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00132-9 · Cited by 415
Serotonin transporter gene polymorphism and antidepressant response
Kim, D. K., Lim, S.-W., Lee, S., Sohn, S. E., Kim, S., Hahn, C. G., & Carroll, B. J. (2000) · NeuroReport · doi:10.1097/00001756-200001170-00042 · Cited by 398
(1996) · PubMed · Cited by 328
Dechant, K. L., & Clissold, S. P. (1991) · Drugs · doi:10.2165/00003495-199141020-00007 · Cited by 325
Zanardi, R., Benedetti, F., Di Bella, D., Catalano, M., & Smeraldi, E. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00021 · Cited by 308
Pharmacogenetics of Antidepressant Medication Intolerance
Murphy, G. M., Kremer, C., Rodrigues, H. E., & Schatzberg, A. F. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1830 · Cited by 283
Self-citationYu, Y. W.-Y., Tsai, S.-J., Chen, T.-J., Lin, C.-H., & Hong, C.-J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001141 · Cited by 246
Yoshida, K., Ito, K., Sato, K., Takahashi, H., Kamata, M., Higuchi, H., Shimizu, T., Itoh, K., Inoue, K., Tezuka, T., et al. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00287-1 · Cited by 226
Zanardi, R., Serretti, A., Rossini, D., Franchini, L., Cusin, C., Lattuada, E., Dotoli, D., & Smeraldi, E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01118-0 · Cited by 219
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F., Kremer, C., Rodrigues, H. E., & Murphy, G. M. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200209000-00007 · Cited by 215
Self-citationMinov, C., Baghai, T. C., Schüle, C., Zwanzger, P., Schwarz, M. J., Zill, P., Rupprecht, R., & Bondy, B. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01704-9 · Cited by 189
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment
Perlis, R. H., Mischoulon, D., Smoller, J. W., Wan, Y.-J. Y., Lamon-Fava, S., Lin, K.-M., Rosenbaum, J. F., & Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00424-4 · Cited by 177
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.5.541 · Cited by 146
Self-citationde Boer, T., Nefkens, F. E. W., Helvoirt, A. V., & Delft, A. M. L. V. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12943-1 · Cited by 123
Age-related decline in central serotonin transporter availability with [123I]β-CIT SPECT
van Dyck, C. H., Malison, R. T., Seibyl, J. P., Laruelle, M. A., Klumpp, H., Zoghbi, S. S., Baldwin, R. M., & Innis, R. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00152-4 · Cited by 119
Age-related decline of serotonin transporters in living human brain of healthy males
Yamamoto, M., Suhara, T., Okubo, Y., Ichimiya, T., Sudo, Y., Inoue, M., Takano, A., Yasuno, F., Yoshikawa, K., & Tanada, S. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01745-9 · Cited by 95
Bosker, F. J., Klompmakers, A. A., & Westenberg, H. G. M. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00023-y · Cited by 78
Malagié, I., Deslandes, A., & Gardier, A. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00486-6 · Cited by 70
Takahashi, H. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00056-1 · Cited by 55
Murphy, G. M., Kremer, C. M. E., Rodrigues, H. E., & Schatzberg, A. F. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00174-4 · Cited by 47
Self-citationEdenberg, H. J., & Reynolds, J. K. (1998) · Psychiatric Genetics · doi:10.1097/00041444-199800830-00011 · Cited by 28
Cited by
Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S., Egan, M. F., Mattay, V. S., Hariri, A. R., & Weinberger, D. R. (2005) · Nature Neuroscience · doi:10.1038/nn1463 · Cited by 1,980
“), and s alleles adversely affect outcome of SSRI treatmen”
BackgroundAnderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Major depressive disorder: new clinical, neurobiological, and treatment perspectives
Kupfer, D. J., Frank, E., & Phillips, M. L. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60602-8 · Cited by 894
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Genetics of emotional regulation: the role of the serotonin transporter in neural function
Hariri, A. R., & Holmes, A. (2006) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2006.02.011 · Cited by 669
Metadata
- Authors
- Murphy, G. M., Hollander, S. B., Rodrigues, H. E., Kremer, C., & Schatzberg, A. F.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2004-11-01
- Volume
- 61
- Issue
- 11
- Pages
- 1163
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2053730389
- Cited by
- 275
- References
- 27
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.